Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Scott R Garrison

Showing results (21-30 of 35) with videos related to

Pageof 4
Sort By:
The Cochrane Database of Systematic Reviews|December 17, 2024
Higher blood pressure targets for hypertension in older adultsJamie M Falk, Liesbeth Froentjes, Jessica Em Kirkwood, et al.
BMJ Open|August 1, 2023
Bedtime versus morning use of antihypertensives in frail continuing care residents (BedMed-Frail): protocol for a prospective, randomised, open-label, blinded end-point pragmatic trialScott R Garrison, Erik Youngson, Danielle A Perry, et al.
Annals of Family Medicine|January 16, 2020
The Effect of Warfarin Administration Time on Anticoagulation Stability (INRange): A Pragmatic Randomized Controlled TrialScott R Garrison, Lee Green, Michael R Kolber, et al.
Canadian Family Physician Medecin De Famille Canadien|June 14, 2019
Quality of warfarin management in primary care: Determining the stability of international normalized ratios using a nationally representative prospective cohortSharon Liu, Alexander Singer, Finlay A McAlister, et al.
BMJ Open|August 29, 2024
Antihypertensive deprescribing in frail long-term care residents (OptimizeBP): protocol for a prospective, randomised, open-label pragmatic trialRoni Y Kraut, Erik Youngson, Cheryl A Sadowski, et al.
JAMA Network Open|May 12, 2025
Bedtime vs Morning Antihypertensive Medications in Frail Older Adults: The BedMed-Frail Randomized Clinical TrialScott R Garrison, Erik R E Youngson, Danielle A Perry, et al.
Canadian Family Physician Medecin De Famille Canadien|October 13, 2023
Lipid-lowering therapies for cardiovascular disease prevention and management in primary care: PEER umbrella systematic review of systematic reviewsNicolas Dugré, Adrienne J Lindblad, Danielle Perry, et al.
Pilot and Feasibility Studies|May 18, 2023
Team approach to polypharmacy evaluation and reduction: feasibility randomized trial of a structured clinical pathway to reduce polypharmacyDee Mangin, Larkin Lamarche, Gina Agarwal, et al.
BMJ Open|June 6, 2023
Tolerability of bedtime diuretics: a prospective cohort analysisScott R Garrison, Michael Kelmer, Tina Korownyk, et al.
BMJ Open|February 25, 2022
Bedtime versus morning use of antihypertensives for cardiovascular risk reduction (BedMed): protocol for a prospective, randomised, open-label, blinded end-point pragmatic trialScott R Garrison, Michael R Kolber, G Michael Allan, et al.
Pageof 4

Showing results (21-30 of 35) with videos related to

Sort By:
Pageof 4
The Cochrane Database of Systematic Reviews|December 17, 2024
Higher blood pressure targets for hypertension in older adultsJamie M Falk, Liesbeth Froentjes, Jessica Em Kirkwood, et al.
BMJ Open|August 1, 2023
Bedtime versus morning use of antihypertensives in frail continuing care residents (BedMed-Frail): protocol for a prospective, randomised, open-label, blinded end-point pragmatic trialScott R Garrison, Erik Youngson, Danielle A Perry, et al.
Annals of Family Medicine|January 16, 2020
The Effect of Warfarin Administration Time on Anticoagulation Stability (INRange): A Pragmatic Randomized Controlled TrialScott R Garrison, Lee Green, Michael R Kolber, et al.
Canadian Family Physician Medecin De Famille Canadien|June 14, 2019
Quality of warfarin management in primary care: Determining the stability of international normalized ratios using a nationally representative prospective cohortSharon Liu, Alexander Singer, Finlay A McAlister, et al.
BMJ Open|August 29, 2024
Antihypertensive deprescribing in frail long-term care residents (OptimizeBP): protocol for a prospective, randomised, open-label pragmatic trialRoni Y Kraut, Erik Youngson, Cheryl A Sadowski, et al.
JAMA Network Open|May 12, 2025
Bedtime vs Morning Antihypertensive Medications in Frail Older Adults: The BedMed-Frail Randomized Clinical TrialScott R Garrison, Erik R E Youngson, Danielle A Perry, et al.
Canadian Family Physician Medecin De Famille Canadien|October 13, 2023
Lipid-lowering therapies for cardiovascular disease prevention and management in primary care: PEER umbrella systematic review of systematic reviewsNicolas Dugré, Adrienne J Lindblad, Danielle Perry, et al.
Pilot and Feasibility Studies|May 18, 2023
Team approach to polypharmacy evaluation and reduction: feasibility randomized trial of a structured clinical pathway to reduce polypharmacyDee Mangin, Larkin Lamarche, Gina Agarwal, et al.
BMJ Open|June 6, 2023
Tolerability of bedtime diuretics: a prospective cohort analysisScott R Garrison, Michael Kelmer, Tina Korownyk, et al.
BMJ Open|February 25, 2022
Bedtime versus morning use of antihypertensives for cardiovascular risk reduction (BedMed): protocol for a prospective, randomised, open-label, blinded end-point pragmatic trialScott R Garrison, Michael R Kolber, G Michael Allan, et al.
Pageof 4